Stock

Castle Biosciences, Inc. CSTL

$25.06-1.59%

All stocks Create account to unlock

Overview

CSTL market data

Price History

CSTL price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for CSTL. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

8 captured

Castle Biosciences Receives Approval For AdvanceAD-Tx Test From New York State Department Of Health · Jul 14, 2026, 8:32 PM

Castle Biosciences Announces Published Study In 'Dermatology And Therapy' Showing DecisionDx-Melanoma Test Outperforms MIA Nomogram In Predicting Sentinel Lymph Node Positivity Risk · Jun 25, 2026, 8:40 PM

This Keurig Dr Pepper Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday · Jun 25, 2026, 4:25 PM

This PVH Analyst Turns Bearish; Here Are Top 3 Downgrades For Thursday · Jun 25, 2026, 2:20 PM

This Tonix Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday · Jun 25, 2026, 12:50 PM

Winner of My Stock-Picking Derby Sold Her Top Pick Too Soon · May 14, 2026, 11:15 AM

BTIG Maintains Buy on Castle Biosciences, Lowers Price Target to $40 · May 13, 2026, 9:48 AM

8-K filing — CASTLE BIOSCIENCES INC (CSTL) · May 6, 2026, 8:07 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock